IPP Bureau
WHO selects Biological E for mRNA tech transfer
By IPP Bureau - April 03, 2022
Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer
New data indicate molnupiravir eliminates Covid-19 rapidly
By IPP Bureau - April 03, 2022
Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10
Lonza Joins International Pharmaceutical Aerosol Consortium
By IPP Bureau - April 01, 2022
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Bayer to set up 27 telemedicine centres across eight states
By IPP Bureau - April 01, 2022
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
Wipro GE Healthcare launches facility under govt’s PLI scheme
By IPP Bureau - April 01, 2022
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
By IPP Bureau - April 01, 2022
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Premas Life Sciences to handle Beckman’s liquid handling solutions in India
By IPP Bureau - April 01, 2022
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President
By IPP Bureau - April 01, 2022
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
Oragnon enters global licencing agreement with Dare Biosciences
By IPP Bureau - April 01, 2022
An estimated 21 million American women experience BV
Arzeda closes US$33 million Series B funding
By IPP Bureau - April 01, 2022
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
Sumitomo Chemical to build new API and intermediates plant in Japan
By IPP Bureau - April 01, 2022
The plant is scheduled to come on stream in September 2024
Evonik restructures health care business
By IPP Bureau - April 01, 2022
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
USFDA seeks more analysis on Merck’s BLA for Vaxneuvance
By IPP Bureau - April 01, 2022
No new studies have been requested
Dr. Reddy's to acquire cardiovascular brand Cidmus in India
By IPP Bureau - April 01, 2022
The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction
Chief Minister Naveen Patnaik inaugurates Apollo Cancer Centre in Bhubaneswar
By IPP Bureau - April 01, 2022
One of the most advanced cancer care centres in the state of Odisha, it is equipped with the latest technology and a highly experienced multi-disciplinary team of oncologists
